NZ's Fisher & Paykel sues Resmed in Australia over patent dispute
[BENGALURU] New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.
Fisher & Paykel said it was seeking a range of legal remedies from the lawsuit, including banning the manufacture and sale of such Resmed products in Australia.
The company added its earnings forecast for fiscal 2018 remained unchanged.
Fisher & Paykel and California-based Resmed are engaged in patent disputes in several countries over medical devices used to treat respiratory conditions.
Fisher & Paykel had filed a case against Resmed in Britain in 2016 and said last month it could continue to sell its sleep apnea masks in the country after a UK court ruled Resmed's patent was invalid.
Resmed was not immediately available for a comment.
Fisher & Paykel shares were about one per cent lower after the announcement, in a lower overall market in New Zealand. Resmed's Australia shares were down about one per cent while the larger Australian market traded flat.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action